SIEN logo

Sientra (SIEN) Stock

Profile

Full Name:

Sientra, Inc.

Sector:

Healthcare

Country:

United States

IPO:

29 October 2014

Indexes:

Not included

Description:

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 29, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 23, 2023

Analyst ratings

Recent major analysts updates

13 Nov '23 Stifel
Buy
31 Oct '23 Craig-Hallum
Hold
31 Mar '23 Maxim Group
Buy
31 Mar '23 Craig-Hallum
Buy
25 Oct '22 William Blair
Market Perform
14 Apr '22 Lake Street
Buy
29 Mar '22 Canaccord Genuity
Buy
24 Mar '22 Stifel
Buy
12 May '21 SVB Leerink
Outperform
12 May '21 Canaccord Genuity
Buy

Screeners with SIEN included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Sientra, Inc. (SIEN) Q3 2023 Earnings Call Transcript
Sientra, Inc. (SIEN) Q3 2023 Earnings Call Transcript
Sientra, Inc. (SIEN) Q3 2023 Earnings Call Transcript
SIEN
Seeking Alpha09 November 2023

Sientra, Inc. (NASDAQ:SIEN ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal, Compliance and Corporate Development Officer Ron Menezes - President and Chief Executive Officer Denise Dajles - Chief Technical Officer Andy Schmidt - Chief Financial Officer Conference Call Participants Jordan Bernstein - Stifel Jeremy Pearlman - Maxim Group Operator Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave.

Sientra to Present at the Stifel 2023 Healthcare Conference
Sientra to Present at the Stifel 2023 Healthcare Conference
Sientra to Present at the Stifel 2023 Healthcare Conference
SIEN
GlobeNewsWire08 November 2023

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its participation at the Stifel 2023 Healthcare Conference. As part of the conference, the company's management team will participate in a live fireside chat on Wednesday, November 15, 2023 at 8:00am EST / 5:00am PST.

Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates
SIEN
Zacks Investment Research10 August 2023

Sientra (SIEN) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to loss of $2.90 per share a year ago.

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
SIEN
GlobeNewsWire27 July 2023

IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the second quarter of 2023 after the close of trading on Thursday, August 10, 2023. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
As Sientra Options Become Less Bullish This Week, Short Sellers Are Moving In
SIEN
24/7 Wall Street15 June 2023

After Sientra ( US:SIEN ) announced last week that the FDA had approved the company's tissue expander, the shares' put/call ratio remains very favorable this week, and the number of purchases of SIEN stock options held by investors surged on June 12, data from Fintel shows.

Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
Why Fast-paced Mover Sientra (SIEN) Is a Great Choice for Value Investors
SIEN
Zacks Investment Research05 June 2023

Sientra (SIEN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
Despite Fast-paced Momentum, Sientra (SIEN) Is Still a Bargain Stock
SIEN
Zacks Investment Research18 May 2023

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sientra (SIEN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Sientra, Inc. (SIEN) Q1 2023 Earnings Call Transcript
Sientra, Inc. (SIEN) Q1 2023 Earnings Call Transcript
Sientra, Inc. (SIEN) Q1 2023 Earnings Call Transcript
SIEN
Seeking Alpha11 May 2023

Sientra, Inc. (NASDAQ:SIEN ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Oliver Bennett - Chief Legal Compliance and CDO Ron Menezes - President and CEO Andy Schmidt - Chief Financial Officer Denise Dajles - Chief Technical Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Joe Federico - Stifel Anthony Vendetti - Maxim Group Operator Good afternoon, everybody. And welcome to Sientra's First Quarter 2023 Financial Results Conference Call.

Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
SIEN
GlobeNewsWire01 May 2023

IRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the first quarter of 2023 after the close of trading on Thursday, May 11, 2023. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

Sientra (SIEN) Reports Q4 Loss, Misses Revenue Estimates
Sientra (SIEN) Reports Q4 Loss, Misses Revenue Estimates
Sientra (SIEN) Reports Q4 Loss, Misses Revenue Estimates
SIEN
Zacks Investment Research30 March 2023

Sientra (SIEN) delivered earnings and revenue surprises of -137.50% and 2.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of Sientra?
  • What is the ticker symbol for Sientra?
  • Does Sientra pay dividends?
  • What sector is Sientra in?
  • What industry is Sientra in?
  • What country is Sientra based in?
  • When did Sientra go public?
  • Is Sientra in the S&P 500?
  • Is Sientra in the NASDAQ 100?
  • Is Sientra in the Dow Jones?
  • When was Sientra's last earnings report?
  • When does Sientra report earnings?
  • Should I buy Sientra stock now?

What is the primary business of Sientra?

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

What is the ticker symbol for Sientra?

The ticker symbol for Sientra is NASDAQ:SIEN

Does Sientra pay dividends?

No, Sientra does not pay dividends

What sector is Sientra in?

Sientra is in the Healthcare sector

What industry is Sientra in?

Sientra is in the Medical Devices industry

What country is Sientra based in?

Sientra is headquartered in United States

When did Sientra go public?

Sientra's initial public offering (IPO) was on 29 October 2014

Is Sientra in the S&P 500?

No, Sientra is not included in the S&P 500 index

Is Sientra in the NASDAQ 100?

No, Sientra is not included in the NASDAQ 100 index

Is Sientra in the Dow Jones?

No, Sientra is not included in the Dow Jones index

When was Sientra's last earnings report?

Sientra's most recent earnings report was on 29 March 2024

When does Sientra report earnings?

The date for Sientra's next earnings report has not been announced yet

Should I buy Sientra stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions